For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Epoch Pharmaceuticals, Inc.

USPTO Granted Patents = 21

Forward Citations = 1,069

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Rich B Meyer, Jr (18 out of 30 patents)

Igor V Kutyavin (15 out of 49 patents)

Eugeny Alexander Lukhtanov (9 out of 51 patents)

4. Alexander A Gall (8 out of 47 patents)

5. Howard B Gamper (8 out of 10 patents)

6. Irina Aleksandrovna Afonina (5 out of 26 patents)

7. Michael W Reed (4 out of 33 patents)

8. Robert O Dempcy (2 out of 24 patents)

9. John C Tabone (2 out of 23 patents)

10. Joel Hedgpeth (2 out of 9 patents)

11. Evgeniy S Belousov (2 out of 6 patents)

12. Charles R Petrie (2 out of 26 patents)

13. Gerald D Hurst (2 out of 2 patents)

14. Yung-Chi Cheng (1 out of 61 patents)

15. Michael J Singer (1 out of 5 patents)

21 patents: Sort by Forward Citations

1. 6949367 - Modified oligonucleotides for mismatch discrimination (2005-09-27),

2. 6727356 - Fluorescent quenching detection reagents and methods (2004-04-27),

3. 6492346 - Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders (2002-12-10),

4. 6485906 - Oligonucleotides containing pyrazolo[3,4-d]pyrimidines for hybridization and mismatch discrimination (2002-11-26),

5. 6312953 - Bifunctional Crosslinking oligonucleotides adapted for linking to a target sequence of duplex DNA (2001-11-06),

6. 6312925 - Methods and compositions to facilitate D-loop formation by oligonucleotides (2001-11-06),

7. 6312894 - Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders (2001-11-06),

8. 6143877 - Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in (2000-11-07),

9. 6136601 - Targeted mutagenesis in living cells using modified oligonucleotides (2000-10-24),

10. 6127121 - Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization (2000-10-03),

11. 6084102 - Covalently linked oligonucleotide minor grove binder conjugates (2000-07-04),

12. 6072046 - Diaziridinyl-aryl and bis-[di(chloroethyl)amino]-aryl oligonucleotide (2000-06-06),

13. 5935830 - Targeted mutagenesis in living cells using modified oligonucleotides (1999-08-10),

14. 5912340 - Selective binding complementary oligonucleotides (1999-06-15),

15. 5849482 - Crosslinking oligonucleotides (1998-12-15),

Epoch Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on developing innovative therapies for various diseases. With a strong commitment to research and development, we strive to improve the lives of patients worldwide. Our portfolio includes cutting-edge treatments in oncology, neurology, and rare diseases. Visit our website for more information on our products and pipeline.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

21 Patents

#25 in Bothell, WA

#335 in Washington

#15,661 in US

#29,874 in the World

Bothell, WA, United States of America

Epoch Pharmaceuticals, Inc.

Forward Citations = 1,069

21 inventors:

Rich B Meyer, Jr (18 out of 30 patents)

Igor V Kutyavin (15 out of 49 patents)

Eugeny Alexander Lukhtanov (9 out of 51 patents)

4. Alexander A Gall (8 out of 47 patents)

5. Howard B Gamper (8 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…